Loading…
CIK 0001306923 • 8 13F filings • May 15, 2025 – Aug 19, 2026
Import this data to Google Sheets with:
=jivedata("palo-alto-investors-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABEONA THERAPEUTICS INC | COM NEW | $518K | 0.1% | 108,865 SH | |
| ACADIA PHARMACEUTICALS INC | COM | $44.2M | 8.4% | 2,663,925 SH | |
| ACELYRIN INC | COM | $4.4M | 0.8% | 1,792,895 SH | |
| ACLARIS THERAPEUTICS INC | COM | $1.2M | 0.2% | 776,028 SH | |
| AGIOS PHARMACEUTICALS INC | COM | $8.1M | 1.5% | 276,578 SH | |
| AKARI THERAPEUTICS PLC-ADR | SPONSORED ADR | $181K | 0.0% | 146,024 SH | |
| ALDEYRA THERAPEUTICS INC | COM | $1.3M | 0.2% | 225,465 SH | |
| ALIGN TECHNOLOGY INC | COM | $6.0M | 1.1% | 37,772 SH | |
| ALKERMES PLC | SHS | $7.3M | 1.4% | 221,513 SH | |
| ALNYLAM PHARMACEUTICALS INC | COM | $22.5M | 4.3% | 83,488 SH | |
| AMICUS THERAPEUTICS INC | COM | $59.9M | 11.4% | 7,345,002 SH | |
| ANAPTYSBIO INC | COM | $19.0M | 3.6% | 1,020,713 SH | |
| BICYCLE THERAPEUTICS PLC-ADR | SPONSORED ADS | $2.1M | 0.4% | 248,934 SH | |
| BIOGEN INC | COM | $28.0M | 5.3% | 204,923 SH | |
| BIOMARIN PHARMACEUTICAL INC | COM | $70.1M | 13.3% | 991,207 SH | |
| BIONTECH SE-ADR | SPONSORED ADS | $2.3M | 0.4% | 25,206 SH | |
| DYNE THERAPEUTICS INC | COM | $3.5M | 0.7% | 333,391 SH | |
| EDWARDS LIFESCIENCES CORP | COM | $2.9M | 0.5% | 39,473 SH | |
| EHEALTH INC | COM | $11.3M | 2.1% | 1,684,336 SH | |
| GENERATION BIO CO | COM | $61K | 0.0% | 150,475 SH | |
| GOSSAMER BIO INC | COM | $6.9M | 1.3% | 6,276,893 SH | |
| HUMANA INC | COM | $1.1M | 0.2% | 3,985 SH | |
| INSMED INC | COM PAR $.01 | $75.3M | 14.3% | 987,153 SH | |
| INSTIL BIO INC | COM NEW | $194K | 0.0% | 11,165 SH | |
| IOVANCE BIOTHERAPEUTICS INC | COM | $10.7M | 2.0% | 3,211,314 SH | |
| KARYOPHARM THERAPEUTICS INC | COM | $1.2M | 0.2% | 324,032 SH | |
| MIRUM PHARMACEUTICALS INC | COM | $2.9M | 0.6% | 64,700 SH | |
| NEUROCRINE BIOSCIENCES INC | COM | $1.5M | 0.3% | 13,334 SH | |
| NOVOCURE LTD | ORD SHS | $17.9M | 3.4% | 1,002,061 SH | |
| NUVATION BIO INC | COM CL A | $1.4M | 0.3% | 772,652 SH | |
| PROTHENA CORP PLC | SHS | $20.5M | 3.9% | 1,659,734 SH | |
| PTC THERAPEUTICS INC | COM | $20.6M | 3.9% | 404,196 SH | |
| PYXIS ONCOLOGY INC | COMMON STOCK | $1.0M | 0.2% | 1,037,421 SH | |
| RELMADA THERAPEUTICS INC | COM | $134K | 0.0% | 495,146 SH | |
| SAREPTA THERAPEUTICS INC | COM | $13.4M | 2.6% | 210,258 SH | |
| STAAR SURGICAL CO | COM PAR $0.01 | $9.3M | 1.8% | 525,017 SH | |
| STOKE THERAPEUTICS INC | COM | $837K | 0.2% | 125,861 SH | |
| SYNDAX PHARMACEUTICALS INC | COM | $5.5M | 1.0% | 444,367 SH | |
| TAYSHA GENE THERAPIES INC | COM SHS | $2.0M | 0.4% | 1,419,468 SH | |
| TRAVERE THERAPEUTICS INC | COM | $2.0M | 0.4% | 110,719 SH | |
| UNITED THERAPEUTICS CORP | COM | $32.4M | 6.2% | 105,228 SH | |
| UROGEN PHARMA LTD | COM | $271K | 0.1% | 24,500 SH | |
| VERVE THERAPEUTICS INC | COM | $2.6M | 0.5% | 575,817 SH | |
| VYNE THERAPEUTICS INC PIPE | COM | $704K | 0.1% | 445,434 SH |
| 13F-HR/A |
| 0002073679-26-000102 |
| $723.7M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001306923-25-000016 | $470.0M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001306923-26-000004 | $653.9M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001306923-25-000014 | $525.1M | View |